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Abstract
Chronic immune activation and progression to AIDS are observed after SIV infection in macaques but not in natural host
primate species. To better understand this dichotomy, we compared acute pathogenic SIV infection in pigtailed macaques
(PTs) to non-pathogenic infection in African green monkeys (AGMs). SIVagm-infected PTs, but not SIVagm-infected AGMs,
rapidly developed systemic immune activation, marked and selective depletion of IL-17-secreting (Th17) cells, and loss of
the balance between Th17 and T regulatory (Treg) cells in blood, lymphoid organs, and mucosal tissue. The loss of Th17 cells
was found to be predictive of systemic and sustained T cell activation. Collectively, these data indicate that loss of the Th17
to Treg balance is related to SIV disease progression.
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Introduction
Progressive disease caused by the human immunodeficiency
virus, type 1 (HIV) is marked by systemic inflammation and
immune dysregulation, most notably CD4+ T cell depletion
[1,2,3,4]. Insights into HIV-induced pathogenesis have been
provided by studying SIV infection of non-human primates [5],
wherein outcomes can be diametrically opposed depending on the
species used. Thus, SIV infection of macaques leads to a disease
syndrome indistinguishable from that induced by HIV in humans
[6,7,8]. By contrast, SIV infection of the African green monkey
(AGM) results in high viral loads in blood and lymphoid tissues,
but limited inflammation and chronic immune activation, and no
pathology [6,9,10,11,12].
Although it is not clear why some lentiviral infections trigger
high levels of inflammation while others do not, it is evident that
decisive host-pathogen interactions take place early after infection
and can be determinants of disease progression. Acute HIV
infection is associated with an early peak in viremia followed by
partial resolution and the establishment of relatively stable ‘‘set
points’’ in viral load and immune activation. Of these two
parameters, the level of immune activation has been found to most
accurately predict the rate of subsequent disease progression,
independently of viral load [13,14,15]. The mechanisms by which
this ‘‘immune activation set point’’ is established after acute
infection have been difficult to elucidate. It is known, for example,
that pathogenic SIV and HIV infections lead to rapid depletion of
CD4+ T cells in the lamina propria of the gut, with impaired
integrity of the mucosal epithelium, enhanced bacterial transloca-
tion, and perhaps systemic immune activation [16,17]. However,
acute CD4+ T cell depletion in the gut also occurs in the setting of
‘‘nonpathogenic’’ SIV infection [18,19], raising the question as to
when and how differential host responses to lentiviral infection are
in fact established.
To more carefully define how lentiviral infections may cause
immune activation and disease, we investigated the early events
that occur in blood and hematolymphoid organs after pathogenic
and nonpathogenic SIV infection. We hypothesized that a critical
distinction between pathogenic and nonpathogenic infections may
lie in a shift in the equilibrium between pro- and anti-
inflammatory host immune responses during acute infection.
Because helper CD4+ T cells orchestrate critical functions in the
immune system through the production of distinct cytokine
profiles [20], we investigated more specifically the relative
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frequency of subset populations of T helper cells, including two
unique subsets under balanced and reciprocal patterns of
differentiation: Th17 cells, producing the proinflammatory
cytokine IL-17, and Tregs, whose function is instead immunosup-
pressive [21,22]. Th17 cells, in particular, have been causally
related both to chronic inflammatory diseases [23] and to host
defenses against microbial agents [24]. Our data collectively
indicate that pathogenic SIV infection results in the loss of balance
between Th17 and Treg populations, whereas this balance is
maintained in nonpathogenic infections.
Results
SIV infection of the PT, but not the AGM, results in T cell
activation and generalized CD4+ T cell depletion
The primary isolate SIVagm.Sab92018 was used to infect (IV,
600 TCID50) four pigtailed macaques (PT; Macaca nemestrina) and
four African green monkeys (AGM; Chlorocebus sabaeus). This
primary isolate is derived from a wild-caught chronically SIV-
infected C. sabaeus AGM from Senegal [25] and causes AIDS in
50% of infected pigtailed macaques within two years (I. Pandrea,
manuscript in preparation), consistent with a prior report
establishing SIV infection of pigtailed macaques with SIVagm
isolates to be pathogenic [7]. Peripheral blood was obtained at
time points before (days 214, 0) and after (days 3, 10, 17, 28, and
45 or 49) infection; lymph node, bone marrow, and colon were
biopsied on days 214 and 10, and harvested at necropsy on days
45 or 49 (subsequently referred to as day ‘‘45+’’). To define the
relative importance of pro- versus anti-inflammatory host immune
responses in pathogenic and nonpathogenic infections, samples
were processed for comprehensive virologic, immunologic,
histologic, and gene expression analyses.
In both species, and as expected [26], SIV viremia was
detectable in PTs and AGMs by day 3 post-infection and reached
high peak levels by day 10 (Figure S1A), after which it declined
and remained stable at high viral ‘‘set-points’’ until the termination
of the experiment (day 45+). The plasma viral load in the PT was
consistently higher than that found in the AGM (p,0.02). Within
cells from various anatomic compartments, however, viral loads in
the PT were found to be higher only at scattered time points, e.g.,
at day 3 in peripheral blood mononuclear cells (PBMCs), at day
45+ in the lymph node, and at day 10 in the colon (Figure 1A).
Notwithstanding the similar kinetics of virus replication post-
infection, PTs and AGMs showed different patterns of T cell
activation. In the PT but not the AGM, CD4+ T cell activation
(Ki67+ and HLA-DR+) was robust and sustained in PBMCs, lymph
node, and bone marrow (Figures 1B and S1B), and persisted in the
colon of both species until day 45+ (Figure 1B, lower). In CD8+T cells
from peripheral blood, Ki67+CD8+ cells peaked by day 17 in both
PTs and AGMs, with a delayed increase in HLA-DR+CD8+ cells
(Figure 1C, upper). Subsequently, immune activation (Ki67+) of
circulating CD8+T cells reached a plateau in PTs by day 28, whereas
it progressively returned to baseline levels in AGMs by day 45+.
Between days 10 and 45+, CD8+ T cell immune activation (Ki67+)
was increased in the lymph node and bone marrow of PTs but not
AGMs, but persisted in the colon of both species (Figure 1C, lower).
Concordant with these results, histological examination of the lamina
propria in the colon of both species showed an infiltration of
Ki67+CD8+ T cells at day 45+ whereas, by this time, the density of
Ki67+CD8+ T cells in the lymph node was only significantly
increased in the PT (Figure S1C). Finally, sustained and generalized
immune activation (Ki67+) was observed at necropsy (day 45+) in
PBMCs, spleen, tonsil, bone marrow, thymus, axillary, iliac, and
mesenteric lymph nodes, jejunum, and ileum of PTs but not AGMs
(Figure 1D), and markers of inflammation (CXCL9/MIG) were
increased in lymph nodes of PTs but not AGMs at early (day 10) as
well as late (day 45+) time points after infection, while only slightly
increased in colonic mucosal tissue of both species at later time points
(Figure S1D).
These patterns of T cell activation closely approximated the
kinetics of CD4+ T cell depletion in each organ studied. Thus,
persistent T cell activation in the PT was associated with CD4+ T
cell depletion in peripheral blood, lymph node, bone marrow, and
colon (Figures 1E and S1E). In the AGM, the frequency and
absolute number of circulating CD4+ T cells was lower than that
of the PT prior to infection (see Text S1), but unchanged after
infection (Figures 1E and S1E). The CD4+ T cell compartment of
the SIV-infected AGM was also spared in the lymph node and
bone marrow, but rapid and persistent CD4+ T cell depletion
occurred in the colon, as has been reported previously [18]
(Figures 1F and S1E). In addition, both PTs and AGMs were
found to maintain a large population of memory CD4+ T cells,
suggesting that differences in cytokine-producing T helper
populations are not likely due to differential loss of this memory
cell subset (Figure S1F and S1G, Text S2). Changes in the
numbers of T cell subsets at various lymphoid sites in SIV
infection have been described previously [18,25,27,28,29]. Al-
though we observed a trend toward transient peripheral CD4+ T
cell decline at day 10 in AGMs, this did not reach significance,
presumably due to low baseline CD4+ T cell counts in these older
AGMs. Of note, an abundant population of CD3+CD42CD82
‘‘double negative’’ (CD3+DN) cells was observed in AGMs prior to
SIV infection and remained unchanged after infection in the
peripheral blood, lymph node, and colon (Figure S1E and S1F and
Text S3).
Altogether, these findings indicate that both PTs and AGMs
respond to SIV infection with acute and generalized T cell
immune activation. Such activation continues unabated in the PT
and is accompanied by CD4+ T cell depletion in multiple
anatomic compartments. The AGM, by contrast, is able to
dampen T cell immune activation in all compartments except the
colon, wherein CD4+ T cell depletion occurs.
Author Summary
Natural infection by the simian immunodeficiency virus
(SIV) in over 40 different species of African non-human
primates is not accompanied by progression to acquired
immunodeficiency syndrome (AIDS). To understand this
phenomenon, we have performed a detailed virologic,
immunologic, and gene expression analysis of acute SIV
infection of two disparate species: the African green
monkey (AGM), in which SIV infection is nonpathogenic,
and the Asian pigtailed macaque (PT), in which SIV
infection results in AIDS. After experimental infection,
animals of both species developed high viral loads. In the
PTs, viremia was associated with CD4+ T cell depletion in
the peripheral blood and multiple signs of persistent
immune activation and inflammation. Such pathology was
not observed in AGMs. Notably, the AGMs maintained high
and balanced levels of two subset populations of CD4+ T
cells, e.g., the immunosuppressive T regulatory (Treg) and
the IL-17 producing (Th17) populations, whereas the PTs
did not. Further analysis of the role of Th17 and Treg
balance during pathogenic lentiviral infection may provide
novel insights into our understanding of SIV and HIV
pathogenesis and future thoughts about vaccine devel-
opment.
Loss of Th17 and Treg Balance in SIV Infection
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Figure 1. Virus load, T cell activation, and CD4+ and CD8+ T cell changes after SIV infection of PTs and AGMs. (A) Cellular RNA virus load
in PBMCs, lymph node, and colon (per mg of total RNA), before and after inoculation of 4 PTs and 4 AGMs with the SIVagm isolate, SIVagm.sab92018
(600 TCID50). (B and C) Fraction of cells positive for Ki67 and HLA-DR amongst total CD4
+ (B) and CD8+ (C) T cells from peripheral blood (PBMCs),
lymph node, colon, and bone marrow. (D) Ki67+CD8+ T cells in multiple hematolymphoid organs at necropsy in a representative PT (A99059) and
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CD4+ T cell depletion in the PT is accompanied by
distinct inflammatory responses
To investigate whether the CD4+ T cell depletion in PTs
correlated with differential changes in systemic inflammation and
cytokine responses, we analyzed circulating cytokines and acute
stress proteins in plasma. This analysis revealed high and sustained
levels of IFNa and IL-12, as well as an acute elevation of
lipopolysaccharide-binding protein (LBP) and of IL-6 in the
peripheral blood of PTs but not of AGMs (Figure 2A).
We further analyzed the transcriptional profiles of IFNa-
induced genes and of cytokines/chemokines by microarray in the
peripheral blood and colon of PTs and AGMs at the peak of
viremia (day 10) and at set point (days 45+) relative to baseline (day
214). In temporal concordance with the elevated levels of IFNa
observed in the peripheral blood, a constellation of IFNa-induced
transcripts was observed in the peripheral blood and colon of both
PTs and AGMs at day 10 (Figure 2B). The levels of many of these
returned to baseline by day 45+ in AGMs but not in PTs, in whom
increased transcript levels from certain genes and gene families
(e.g., PML, IFIs, OAS1, MX) persisted to day 45+. In other cases
(e.g., IRF1 and INDO), the patterns of expression were different,
with increased levels in PTs and decreased levels in AGMs at both
early and late time points.
Transcriptional profiling of cytokines/chemokines in the colon
of PTs and AGMs revealed additional differences in the response
of these two species to SIV infection (Figure 2C). In PTs but not in
AGMs, the peak of viremia (day 10) was associated with enhanced
transcription of genes associated with acute inflammation and
bacterial infection (e.g., IL-1b, IL-22, S100A8-9) [30], and with
the chemotaxis of activated and differentiated Th1 and myeloid
cells (e.g., CXCL9/MIG, CXCL11/I-TAC, CCL23/MPIF-1),
while transcriptional levels of some genes associated with the
chemotaxis of resting T cells and immature dendritic cells (e.g.,
CCL28/MEC, CCL20/LARC) were reduced (Figure 2C, R1–
R2). By contrast, the transcription of CCL20/LARC and
CXCL1-2/GRO was acutely elevated in AGMs but significantly
and durably reduced in PTs, suggesting a change in Th17
environment with the recruitment of neutrophils (CXCL1-2),
immature dendritic cells, and CCR6-expressing Th17 cells
themselves (CCL20) [31,32] (Figure 2C, R1). Both PTs and
AGMs showed enhanced transcription of a number of genes in the
colon at days 45+, in a pattern consistent with increased
myelopoiesis and B lymphopoiesis (e.g., CXCL12), and with the
establishment of an anti-inflammatory and immuno-protective
response (e.g., TGFb1I1, 2, and 3, PTGS1-2/COX1-2)
(Figure 2C, R3).
In aggregate, these results reveal an acute inflammatory
environment in PTs that is biased towards a Th1 response, more
so than that which is found in AGMs. They also reinforce the
conclusion that the AGM is able to dampen many gene functions
associated with inflammation after the peak viral load (day 10), a
point elaborated in a companion paper detailing the kinetics and
anatomic location of gene expression changes in these species after
SIV infection (Lederer et al.). We hypothesized that this
dichotomy between the species might be due to the fact that
pathogenic infection of the PT is driven by an increased frequency
of pro-inflammatory Th17 cells [23,24,33] and/or a decreased
frequency of anti-inflammatory Tregs [27,34]. Further examina-
tion of this hypothesis provided unexpected results.
IL-17-expressing Th17 cells are lost after SIV infection of
the PT but not of the AGM
Th17 cells in blood and tissues of PTs and AGMs were
identified by intracellular cytokine detection of the Th17-defining
cytokine, IL-17A, in T cells stimulated with PMA and ionomycin.
As has been found in human Th17 CD4+ T cells [31], CD4+ Th17
cells in the PT and AGM were of a lineage distinct from Th1,
Th2, or Tregs cells (i.e., they produced only minimal amounts of
IFNc and no MIP1b, IL-4, IL-10, or TGFb) (Figure 3A, and data
not shown) and had a memory (CD45RA2CD27+) phenotype
(data not shown). At the same time, a significant fraction of CD4+
Th17 cells produced IL-2 and TNFa (Figure 3A), and expressed
the IL-2 receptor a chain (CD25) in the absence of FoxP3 (data
not shown).
Prior to infection, Th17 CD4+ T cells were detected at the
same frequency in AGMs and PTs (Figure 3B and 3C). After
infection of PTs, the frequency (Figure 3B and 3C, left) and
absolute number (Figure 3C, right) of circulating functional
Th17 cells decreased dramatically; by contrast, Th17 cells were
maintained at constant frequency and absolute number in the
AGM (Figure 3B and 3C). At necropsy (day 45+), the frequency
of functional Th17 cells was maintained at high levels in the
spleen, axillary and iliac lymph nodes, and colon of AGMs but
was substantially reduced in these tissues in PTs (Figure 3D). The
depletion of Th17 cells in the lymph node and colon of PTs was
also evident when mRNA levels of IL-17A or RORc [a specific
lineage marker of Th17 cells [35]] were analyzed by RT-PCR
(Figure 3E and data not shown).
The loss of Th17 cells in PTs is selective
To understand whether the loss of Th17 cells in the PT was
selective or simply due to generalized CD4+ T cell depletion, the
frequency of cytokine-expressing Th1 cells (e.g., expressing
MIP1b, IL-2, TNFa, and/or IFNc) and Th2/Treg cells (e.g.,
expressing IL-4, IL-10, and/or TGFb) was examined in each
species. In both PTs and AGMs, acute SIV infection was
associated with the maintenance of CD4+ T cells producing
IFNc or IL-4, and the loss of those producing TNFa (Figure 4A).
By day 28, MIP1b-producing CD4+ T cells were enriched
(p = 0.02) and IL-2 producing CD4+ T cells were depleted in PTs
but not AGMs (p = 0.004) (Figure 4A). Depletion of IL-2
producing CD4+ T cells was due to the depletion of
multifunctional IL-2+IL-17+(+/2TNFa+) Th17 cells and IL-
2+IFNc+ and/or TNFa+ Th1 cells (Figure S2A and Text S4 for
the analysis of multifunctional cytokine profile, including
antigen-specific responses). To determine whether there was
selective depletion of Th17 cells over other Th populations (e.g.,
those producing IFNc, IL-4, or MIP1b) we measured the ratio
between Th17 cells and these other populations as a function of
time post-infection. All of these ratios declined to significantly
lower levels in PTs, but not in AGMs, by day45+ (Figure 4B). At
this time, selective depletion of Th17 cells compared to all other
cytokine-expressing populations was evident in PTs in blood and
AGM (06006), with the frequency of Ki67+ cells indicated for the PT. (E) CD4+ T cell counts in the peripheral blood as a function of time after infection.
(F) Frequency of CD4+ T cells in biopsies of lymph node, bone marrow, and colon, obtained at the indicated times before and after infection. Data are
presented as means6SEM. Statistical analysis: P values were obtained on a per group basis (*) using the Mann-Whitney nonparametric test (when
comparing PTs to AGMs at a given time point) or over time (#) by ANOVA (linear scale) (comparing each time point separately to baseline, e.g. day
214 and day 0, in PTs or AGMs). When the p value is not indicated on the graph, ‘‘*’’ or ‘‘#,’’ indicate that p,0.05 for each test, respectively.
doi:10.1371/journal.ppat.1000295.g001
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Figure 2. Differential production and transcription of cytokines, chemokines, and IFN-induced genes after SIV infection of PTs and
AGMs. (A) Plasma levels of IFNa, LPS-binding protein (LBP), IL-12, and IL-6, as determined by ELISA. Refer to Figure 1 for a description of statistical
analysis and symbols. (B and C) Microarray analysis of IFNa-induced genes (B) and cytokine/chemokine gene expression (C) in PTs (n = 4) and AGMs
(n = 4) in blood and colon at days 10 and 45+. The data presented are gene expression changes calculated from technical replicate arrays (n = 2) and
error-weighted averages for 4 animals (n = 8 arrays) at day 10 or day 45+ relative to baseline day 214 of each individual (see Materials and Methods,
Table S1 and Protocol S1 for details). Rectangles R1, R2, and R3 (C) depict sets of cytokine and chemokine genes that are differentially regulated in
Loss of Th17 and Treg Balance in SIV Infection
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in all lymphoid tissues at necropsy (Figure S2B and S2C, and
data not shown). In terms of absolute cell numbers, these
changes in the PT were accompanied by an increased number of
circulating Th1 MIP1b-expressing and monofunctional IFNc-
expressing CD4+ T cells in PTs, leading to partial recovery of
Th1 cell counts over time (Figure 4C). As shown in the specific
case of MIP1b (Figure 4D), a detailed kinetic analysis of these
changes in blood indicated that they occurred after acute CD4+
T cell depletion and in parallel with the peak of the CD4+
proliferative (Ki67+) response in PTs. These changes point to de
novo generation of Th1 cells and depletion of multifunctional IL-
2 producing CD4+ T cell populations in PTs but not AGMs
during acute SIV infection, and suggest that the generalized
CD4+ T cell losses observed in the PT are accompanied by
selective depletion of Th17 cells.
FoxP3+ Tregs are sustained in the AGM and transiently
lost in the PT
The frequency and number of FoxP3+CD4+ Tregs was
determined in each species as a function of time post-infection.
In each, these cells showed high levels of CD25, low levels of
CD127 and of intracellular cytokines (e.g. IL-17, IL-2, IFNc and
TNFa) (Figure S3A and S3B, and data not shown), and in vitro
suppressive activity comparable to that observed in the SIV-
infected rhesus macaque [36] (Figure S3C and S3D).
Between days 10–28 after SIV infection, the frequency of
circulating FoxP3+CD4+ T cells increased in both species
(Figure 5A, see also Figure S3E and S3F and Protocol S1 for
details on the gating strategy of FoxP3+CD4+ T cells). Given the
depletion of CD4+ T cells in PTs, however, high absolute numbers
of such cells were found only in AGMs (Figure 5B). Notably, most
FoxP3+CD4+ T cells on days 17 and 28 in PTs (but not AGMs)
were activated (Ki67+) (Figure 5C), consistent with an induced
phenotype in this species [34]. In lymph nodes, AGMs showed an
early increase (day 10) in the frequency of FoxP3+CD4+, which
was sustained to day 45+ (Figure 5D) and that was accompanied
by a stable density of FoxP3+ cells (as measured by quantitative
image analysis) (Figure 5E and 5F, left) and a stable level of FoxP3
transcripts (as measured by RT-PCR) (Figure S3G, upper). In
lymph nodes from PTs, by contrast, the frequency of FoxP3+ cells
was increased only at day 45+ (Figure 5D) and the density
decreased by day 10, returning towards baseline by day 45+
(Figure 5E and 5F, left). Colonic tissue in both species revealed
only a late (day 45+) increase in the density of FoxP3+ T cells
(Figure 5E and 5F, right) and in the level of FoxP3 transcripts
(Figure S3G, lower).
Thus, and contrary to our initial hypothesis, AGMs maintained
a high number and frequency of Th17 cells in peripheral blood
and lymphoid organs whereas PTs with progressive disease
showed early, generalized, and selective depletion of Th17 cells.
Concomitantly, AGMs responded to SIV infection with a rapid
and durable systemic mobilization of FoxP3+CD4+ Tregs whereas,
in PTs, such cells were induced transiently in the blood and only at
later time points in lymph node and colonic tissue. We next
investigated whether the acute changes that occur in these critical
T cell subpopulations post-infection might predict and/or be
associated with immune activation.
Th17 depletion predicts systemic and sustained T cell
immune activation
To investigate the impact of Th17 cells, viral load, and CD4
depletion on systemic immune activation, a mixed-effects analysis
was performed with the frequency of Ki67+CD8+ T cells as the
primary outcome. All post-infection measurements taken in both
species at days 3, 10, 17, 28, and 45+ were included. The predictor
variables (i.e., Th17 frequency, log10-transformed plasma viral
load, and CD4 counts) were independent time-varying covariates.
As expected, plasma viral load was not predictive whereas Th17
frequency and CD4+ T cell counts were both predictive of T cell
immune activation (Ki67+CD8+) in univariate analysis, thereby
emphasizing the relationship between immune activation and
Th17 frequency and/or between immune activation and patho-
genic outcome (CD4+ T cell depletion), independently of viral load
in this model. Most importantly, in a multivariate mixed-effects
analysis including the frequency of Th17 cells and CD4+ T cell
counts, both variables were independent predictors of T cell
immune activation (21.82 lower CD8+Ki67% per each 1
percentage point higher of CD4+ Th17%, p = 0.004, and
20.036 lower CD8+Ki67% per each 1 percentage point higher
CD4+ T cell counts, p = 0.005). In aggregate, these results
demonstrate that the loss of Th17 cells (but not Th1, Th2 or
Treg cells, data not shown) was a strong and independent
predictor of increased systemic immune activation during acute
SIVagm infection of AGMs and PTs.
At set point, the loss of balance between Th17 and Tregs
correlates with sustained systemic immune activation
Given the counterposing biologic functions and reciprocal
differentiation pathways of Th17 cells and Tregs [21,22,37,38], we
analyzed the relationship between these T cell subpopulations and
signs of disease progression in PTs and AGMs. Combining the
above observations on Th17 and Treg cells post-infection, AGMs
were found to maintain high numbers of both subpopulations in
the peripheral blood, resulting in a relatively stable ratio over time
(Th17/Treg ratio ,2.0 before and after infection) (Figure 6A). By
contrast, SIV infection of PTs was associated with a rapid decrease
in the ratio of circulating Th17 and Treg cells (Figure 6A), due
both to a decreased frequency of Th17 cells (Figure 3B and 3C)
and to an increased frequency of Tregs (Figure 5A) relative to
baseline. By day 28, a 10-fold lower set point ratio (Th17/Treg
,0.2) was reached, in a manner independent of the extent of
CD4+ T cell depletion (Figure 6A). The relative loss of Th17 cells
compared to Tregs in PTs was confirmed by RT-PCR analysis in
the LNs and colon (Figure 6B, p#0.03). This decline was specific
to the Th17/Treg ratio, since the ratios of IFNc-expressing Th1
cells and of IL-4-expressing Th2 cells to Tregs remained steady in
each species during this same time frame (Figure 6C and data not
shown). Most importantly, at the time when set points were
established by day 28/45+, the Th17/Treg ratio in blood, lymph
nodes and colon correlated negatively with sustained immune
activation in blood and in lymph nodes at set point (p#0.05)
(Figure 6D), but not with colon immune activation (p = 0.3). A
similar correlation was found when the Th17/Treg ratio was
related to CD4+ T cell activation (%Ki67+) (p = 0.04, data not
shown). These correlations were also specific to the Th17/Treg
AGMs and PTs over time, including those that are upregulated in AGMs and/or downregulated in PTs at day 10 (R1), upregulated in PTs but not (or
downregulated) in AGMs at day 10 (R2), and upregulated both in PT and in AGMs at day 45+ (R3). Refer to Figure 1 for a description of statistical
analysis and symbols.
doi:10.1371/journal.ppat.1000295.g002
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Figure 3. Acute SIVagm infection results in the loss of Th17 cells in PTs. (A) Multiparameter flow cytometric analysis of mock- or PMA/
ionomycin-stimulated peripheral CD4+ T cells from a representative AGM (06004) at necropsy (day 45+), showing that IL-17-producing cells were
CD4+ cells that produced IL-2 and TNFa, but only minimal amounts of IFNc and no MIP1b. (B) Detection of IL-17 and IFNc within CD3+CD4+ T cells as
a function of time after infection in a representative PT (A99059) and AGM (06006). IL-17 was induced by PMA and ionomycin stimulation in vitro.
(C) Time- and species-dependent changes in the frequency (left) and absolute number (right) of IL-17+CD4+ T cells in the peripheral blood.
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ratio, since ratios of Th17 to MIP1b- or IFNc-expressing Th1 cells
and ratios of Th17 to IL-4-expressing Th2 cells did not correlate
with immune activation set points (data not shown). Thus, a
balanced representation of Th17 and Treg cells was maintained
upon nonpathogenic infection of the AGM. By contrast, SIV
infection of the PT resulted in loss of Th17 cells and induction of
Tregs, culminating in a lower Th17/Treg ratio, high levels of
immune activation, and generalized CD4+ T cell depletion.
Discussion
We report here a comprehensive virologic, histologic, immu-
nologic, and gene expression analysis of acute infection in AGMs
and PTs. Our results confirm and extend previous studies
comparing the correlates of pathogenic versus nonpathogenic
SIV infection in these two species [10,18,25,27]. A number of
novel features are also highlighted by the unique design of this
experiment. First, sustained systemic immune activation (blood,
lymph nodes, spleen) was only observed in PTs, while signs of T
cell activation and inflammation were still observed in the colonic
mucosa of both species. Second, an increase in the frequency of
FoxP3+ Tregs was detected in the blood and in the lymph nodes
after infection of both species, with an earlier and more dramatic
increase in AGMs that correlated with limited or resolved systemic
inflammation and immune activation. Third, functional Th17 cells
were maintained or increased in infected AGMs but were rapidly
lost during the course of progressive SIV disease in PTs. Finally,
and combining these observations at the time when immunological
and viral parameters reached steady state (day28/45+), a normal
ratio of Th17/Treg cells (,2.0) was associated with limited
immune activation and no disease progression, whereas loss of this
ratio was associated with pathology and none of the other ratio
including Th17 to other Th1 and Th2 populations were found to
correlate with immune activation setpoints. These findings
demonstrate, in sum, that nonpathogenic infection in non-human
primates is associated with a state of chronic inflammation that
may be restricted to the colonic mucosa during acute infection.
Concomitantly, signs of such inflammation were not observed in
the peripheral blood and lymphoid tissues, wherein high Th17 cell
numbers and a balanced representation of Th17 and Treg cells
were maintained after acute infection. These studies suggest that
loss of the Th17 to Treg balance during acute infection is related
to and predictive of lentiviral disease progression.
A number of studies have shown that FoxP3+ T regulatory cells
exert anti-inflammatory functions and control self-reactive T cells,
including Th1, Th2, and possibly, Th17 cells [39,40]. In the
context of acute and chronic infectious diseases, the net outcome
of these effects remains unclear [34]. In the context of HIV and
SIV disease, Tregs might decrease chronic immune activation,
thereby slowing disease progression [41]; conversely, they might
inhibit anti-viral immune responses, thereby hastening disease
progression [42,43]. Discriminating between these two counter-
posing effects has been hampered by the difficulty of precisely
identifying distinct subsets of FoxP3+ Tregs in vivo, e.g., induced
versus natural Tregs [44], and their mechanism of suppression in
controlling immune responses [45]. In this study, FoxP3+ T cells in
PTs expressed an activated (Ki67+) phenotype and were increased
at later time points following infection, consistent with the
induction of an adaptive Treg response that exerted limited, if
any, suppression of T cell activation in the periphery. Interestingly,
a late increase in FoxP3+ cells in the lamina propria of both AGMs
and PTs also correlated with increased expression of TGFb2-3
and immune activation, suggesting that induced Tregs were
equally generated in AGMs and PTs at the time of mucosal
immune activation and that they did not exert a significant anti-
inflammatory function in this organ. By contrast, FoxP3+ T cells in
the blood and lymph nodes of AGMs were increased very early,
were not activated, and were sustained at high levels directly after
infection, consistent with the possibility that these cells may exert
an anti-inflammatory effect involved in the resolution of systemic
immune activation which, in turn, may limit viral replication and
spread.
Th17 cells represent a subpopulation of activated (CD25+) and
highly differentiated tissue-tropic CD4+ T cells associated with
autoimmune disorders [23]. By contrast, Tregs may be activated
but are often anergic and their function is by nature immunosup-
pressive [46]. From a teleological standpoint, one may speculate
that the turnover of Th17 cell population is tightly controlled in
vivo by mechanisms such as apoptosis and/or AICD pathways
[47,48], IDO-mediated tryptophan-deprivation [49], or galectin-1
signaling [50], mechanisms that might not pertain to the turnover
of Tregs [51]. If true, Th17 cells might be more sensitive to cell
death induced by viral (including bystander HIV-dependent
GP120-CD4-signaling [52,53,54]) and/or host factors, compared
to Tregs or Th1 (IFNc-secreting) CD4+ T cells, thus accounting
for their selective depletion in the context of pathogenic lentiviral
infection.
The selective depletion of Th17 cells in PTs and their
maintenance in AGMs was unexpected. These cells have been
causally related to the immunopathology of multiple chronic
inflammatory diseases, including allergy, autoimmune disorders,
and allograft rejection [23], and could conceivably play a major
role in the inflammatory state associated with progressive lentiviral
disease. On the other hand, Th17 cells have also been found to
enhance host defenses against microbial agents [33], thereby
maintaining the integrity of the mucosal barrier against microbial
infections [55,56,57,58,59]. Thus, the up-regulation of IL-1b, IL-
22, and the anti-microbial peptides S100A8 and S100A9 in colons
of PTs [30,60], but not of AGMs, reveals a transcriptional
signature suggestive of bacterial translocation and compromised
colonic mucosal integrity [17,30]. Thus, the detailed analysis of
genomic changes in the colon of PTs (see companion paper from
Lederer et al.) revealed an acute stress response in the NF-kB and
TLR signaling pathways (and, in particular, TLR2), consistent
with the loss of mucosal integrity and bacterial translocation in
PTs but not in AGMs. Reciprocally, in the AGM, Th17 cells may
not be ‘‘proinflammatory,’’ but instead capable of reducing
immune activation in and/or to mucosal tissue, thereby decreasing
systemic inflammation by preventing further microbial transloca-
tion and spread [17,61]. This conclusion is supported by recent
studies demonstrating that Th17 depletion in the ileal mucosa
from chronically SIV-infected macaques correlated with increased
systemic dissemination of Salmonella typhimurium [62], and that
(D) Differential representation of IL-17+IFNc2 cells in the peripheral blood, spleen, axillary and iliac lymph nodes, and colon of one PT (A99059) and
one AGM (06004) at necropsy (day 45+). Of note, CD4+ T cells were substantially depleted in colon at this time point in both PTs and AGMs. (E) Real
time PCR detection of changes in the relative proportion of Th17 cells in the colon, as measured by the expression levels of RORc. In (E), Mann-
Whitney nonparametric test was used for log transformed values over time (#) (comparing each time point separately to baseline, e.g. day 214, in
PTs or AGMs). Refer to Figure 1 for a description of statistical analysis and symbols in (C).
doi:10.1371/journal.ppat.1000295.g003
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Th17 cells are preferentially depleted in the gastrointestinal tract
of SIV-infected rhesus macaques [63] and of HIV-infected
individuals, but not of SIV-infected sooty mangabeys [64].
Th17 cells share common chemokine receptors (CCR6, CCR4)
and homing properties (CCL20) [31] with Tregs and are derived
from a common progenitor cell [35,38], the differentiation of
which is dependent upon the stimulation of mucosal dendritic cells
and macrophages by microbial, parasitic, or fungal products
[65,66,67] and cytokines including IL-23, IL-1b and IL-6 [65,68].
Our results showed that Th17 cells were selectively depleted over
Tregs in the PT whereas the production of both populations was
maintained upon acute infection of the AGM, possibly as a
consequence of maintained balanced differentiation from a
common progenitor [35,38]. The maintenance of Th17 cells in
the colon of AGMs but not PTs seems paradoxical, since both
species experienced massive CD4+ T cell depletion, high viral
loads, and late T cell immune activation (Ki67+CD8+ infiltration)
in this compartment. However, AGMs were found to harbor a
large population of CD3+CD42CD82 (CD3+DN) cells that
included FoxP3- and IL-17-expressing cells that may serve to
complement Treg and Th17 function in the colon in the absence
of CD4+ T cells (data not shown). In addition, the preservation of
Th17 cells in lymphoid tissues of AGMs, but not of PTs, may
compensate for Th17 CD4+ T cell depletion in the colonic
mucosa, by continuous recruitment and trafficking to the gut [69].
Despite similar levels of CD8+ T cell immune activation at day
45+ in the colon, the cytokine/chemokine ‘‘signature’’ of each
species differed during early acute infection, suggesting recruit-
ment of CXCR3-expressing Th1 cells (CXCL9) but not CCR6-
expressing Th17 cells (CCL20) in PTs [31,32] (Figure 2C, R1–
R2). In addition, because IL-12 and Th-1 cytokines have been
shown to inhibit Th17 lineage commitment [21], the observed
skewed distribution toward Th1 cells and Th1-type cytokines and
chemokines (e.g., CXCL9, IL-12, and IFNa) in PTs (Figure 2), but
not in AGMs, may further impair subsequent Th17 lineage
commitment, resulting in long-lasting depletion of the Th17 pool
during chronic infection.
The observed relationship between Th17 cells and Tregs in the
AGM prompts reconsideration of the role of these two cell
populations during acute lentiviral infection. For instance, an
increased representation of Tregs in the AGM after acute infection
was not associated with diminished control of virus. Conversely,
high levels of Th17 cells were not associated with enhanced
immune activation and/or inflammation. Instead, Tregs present in
the AGM may control immune activation in lymphoid organs and
the effects of Th17 cells may serve to limit microbial translocation
in the gut, thereby preventing the induction of systemic immune
activation.
At this point in time, it is not feasible to show definitively that
alteration of this balance (e.g., using specific monoclonal
antibodies to modulate the Th17 or Treg populations in vivo)
will have an impact on disease progression. However, we
demonstrate that the rapid loss of Th17 cells and the loss of
Th17/Treg balance in the PT is associated with multiple signs of
progressive lentiviral disease: a rapid decrease of CD4 counts;
sustained immune activation and apoptosis in CD4+ and CD8+ T
cells of all lymphoid compartments; increased and sustained levels
of pro-inflammatory cytokines and IFNa; and increased expres-
sion in situ and by microarray of genes previously associated with
disease progression). By contrast, we also show in this study and in
a companion paper (Lederer et al.) that AGMs responded to
SIVagm-infection with a strong, systemic, and generalized IFNa
response at the peak of SIV viral load which resolved to near
baseline levels when viral setpoints were established. These data, in
particular, indicate that the lack of pathogenicity of SIV infection
of the AGM is not due to primary dysfunction in the IFNa
signaling pathway, as suggested to be the case in SIV-infected
sooty mangabeys [70].
We believe that the results of this study are important for three
reasons. First, they suggest that a balanced representation of both
Tregs and Th17 cells may play a unique and possibly
determinative role in the setting of acute lentiviral infection.
Secondly, the data reported herein underscore a concept likely
important for our understanding of lentiviral pathogenesis: at the
time of acute infection, a robust representation of Tregs (generally
thought to suppress antiviral responses) and of Th17 cells
(generally thought to be proinflammatory and, hence, to enhance
viral replication and spread) might be beneficial to the host – not
detrimental. Finally, this study prompts novel considerations for
future thoughts about HIV vaccine development. Instead of
focusing solely on the elaboration of a robust antiviral adaptive
systemic immune response, it may also be beneficial to elicit
responses that limit mucosal depletion of Th17 cells immediately
after acute infection and that tilt the Th17/Treg balance towards
that found in the AGM. At worst, such a vaccine approach might
result in a viremic state which, like that of the AGM, is ultimately
nonpathogenic. At best, it may lead to a Th17/Treg response that
diminishes the level of immune activation, thereby slowing the
pace of viral replication and spread.
Materials and Methods
Virus
The original SIVagm.sab92018 primary isolate[25] was kindly
provided by Dr. O. Diop at the Pasteur Institute in Dakar, Senegal
(see also Protocol S1 for more details).
SIVagm infection of non-human primates and tissue
collection
All animal and in vitro procedures were performed using
standard protocols and according to guidelines approved by the
University of Washington Environmental Health and Safety
Committee, the Occupational Health Administration, the Primate
Center Research Review Committee, and the Institutional Animal
Care and Use Committee.
The four adult male AGMs (10 years old, weighing 6.0 kg,
interquartile range 5.8–6.2) and four adult male PTs (11 years old,
weighing 16 kg, IQR 15.3–17.0) included in this study were
housed at the Washington National Primate Research Center
(WaNPRC). At day 0, animals were inoculated intravenously with
600 50% tissue culture infectious doses (TCID50) of SIVagm-
Figure 4. Selective depletion of Th17 cells in PTs. (A) Frequency of IFNc, IL-4, IL-2, TNFa, or MIP1b cytokine-producing CD4+ T cells in PBMCs,
detected after PMA and ionomycin stimulation in vitro. (B) Ratio of the fraction of Th17 cells over the fraction of CD4+ T cells producing IFNc, IL-4, or
MIP1b. (C) Cell counts of IFNc and MIP1b cytokine-producing CD4+ T cells in PBMCs. (D) Frequency of CD4+ T cells expressing MIP1b or Ki67 related to
the circulating CD4+ T cell count in PTs as a function of time after infection. In (B), Mann-Whitney nonparametric test was used for ratios over time (#)
(comparing each time point separately to baseline, e.g. day 0, in PTs or AGMs). Refer to Figure 1 for a description of statistical analysis and symbols in
other cases (A and C).
doi:10.1371/journal.ppat.1000295.g004
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Sab92018 and followed until necropsy at day 45 or day 49
(subsequently noted as day 45+). Blood samples were collected at
days 214, 0, 3, 10, 17, 28, and 45+. At days 214, 10, and 45+,
bone marrow aspirates were obtained from the manubrium and
biopsies were obtained from the colon and lymph nodes (axillary
and inguinal) and samples of tissue were also collected at necropsy
(day 45+) from iliac and mesenteric lymph nodes, tonsil, spleen,
thymus, duodenum, jejunum, and ileum. After purification,
PBMCs, LN and colon cells, or cells from other tissues, e.g.,
those obtained at necropsy (see Protocol S1 for more details) were
counted and resuspended at 3–86106 cells/ml for subsequent
phenotyping and functional analysis in R-10 medium [RPMI 1640
medium (Invitrogen, Carlsbad, CA) supplemented with 10% FCS
(Hyclone, Logan, UT), 10 mM Hepes, 2 mM L-glutamine, 50 U/
50 mg of penicillin/streptomycin per ml and 0.1 mM GIBCO
MEM Non-Essential Amino Acid Solution (all from Invitrogen,
Carlsbad, CA)] (see Protocol S1 for more details).
RNA extraction
Viral RNA was purified from plasma using QIAmp Viral RNA
mini-kits (Qiagen). Whole blood was processed for microarrays
with the PreAnalytix PAXgene blood RNA system (Qiagen). For
viral load and gene expression (qRT-PCR) analyses of PBMCs,
total RNA was purified using the RNeasy mini-kit after cell lysis
and homogenization using a QIAshredder (both from Qiagen).
For microarray, gene qRT-PCR, and viral loads on tissues stored
in RNAlater (e.g., colon and lymph node biopsies) or in OCT,
(e.g., additional lymph node biopsies), tissues were homogenized
using a Polytron PT2100 tissue grinder (Kinematica, Switzerland)
and RNA was extracted into TRIZOL Reagent (Invitrogen).
Genomic DNA was removed from total RNA from each biopsy
and from PBMC samples used for real-time gene expression assays
(qRT-PCR) and for viral loads using DNA-free kits (Ambion), and
an RT-free control was added to all PCR reactions to rule out
DNA contamination. RNA concentrations from whole blood,
PBMCs, and tissue samples were quantified on an ND-1000 UV-
Vis spectophotometer (Nanodrop, Wilmington, DE) and con-
trolled for integrity and purity on a capillary electrophoresis system
(Agilent 2100 Bioanalyzer; Agilent Technologies, Santa Clara,
CA) and processed for microarray following standard procedures
(see also Protocol S1 for more details).
Viral load measurement
RNA viral loads in plasma and tissues were measured by real-
time quantitative PCR (ABI PRISM 7700, Applied Biosystem
Foster City, CA) in a one step RT-PCR reaction (HoTaq One
Step-RT PCR Mix; Molecular Cloning Laboratories, South San
Francisco, CA), using primers and probes as previously de-
scribed[25]. Briefly, primers and probes used to measure viral load
in plasma and tissues were: LTR - 59 J15S (59-CTC GGT GTT
CTC TGG TAA G-39), 39 J15S (59-CAA GAC TTT ATT GAG
GCA AT-39), and 15 s probe (59-FAM-CGA ACA CCC AGG
CTC AAG CTG G-TAMRA-39) [all RNase-free and HPLC-
purified products from Integrated DNA Technologies (Coralville,
IA)]. Because SIVagm viral loads in PT macaques were found to
be extremely high, all samples were run twice or more,
independently (in duplicates), using different sources of RNA
standards and positive controls: briefly, RNA standards were
produced in vitro (SP6/T7 transcription kit, Roche, Applied
Science, Indianapolis, IN) from the LTR template made out of
RNA extracts of SIVagm.sab92018(#800) by RT-PCR (primers
T7-LTR-4S (59 - TAA TAC GAC TCA CTA TAG GGA GAA
CTG GGC GGT ACT GGG AGT GGC TT - 39) and LTR-2A
(59 - ACC TAA GGC AAG ACT TTA TTG AGG - 39) from
Integrated DNA Technologies, and subsequently purified (QIamp
Viral RNA kit – Quiagen), DNA treated (DNAse, Ambion) and
controlled for RNA weight and purity. All standards were
compared to internal controls (RNA from plasma other analyzed
samples) and external RNA standards (kindly provided by Dr.
Michaela Muller-Trutwin, Pasteur Institute, Paris, France).
Expression microarray and real-time RT-PCR
Gene expression on whole blood and colon biopsies at days 10
and 45+ was compared to the baseline time point at day 214 for
each tissue and each animal. Equal quantities of total RNA were
amplified with a Low RNA Input Fluorescent Linear Amplifi-
cation kit (Agilent Technologies, Santa Clara, CA). Probe
labeling and microarray slide hybridization were performed
with custom rhesus macaque (Macaca mulatta) oligonucleotide
microarrays containing 22,000 rhesus probes corresponding to
approximately 18,000 unique rhesus genes (see also Protocol S1
for more details). Raw microarray image files were processed
using Feature Extraction 8.1 software (Agilent Technologies) and
entered into a custom-designed relational database (Expression
Array Manager) and analyzed with Rosetta Resolver System 6.0
(Rosetta Biosoftware, Seattle, Washington) and Spotfire Deci-
sion Site for Functional Genomics 8.1 (Spotfire, Somerville,
Massachusetts).
A selected list of two sets of genes, e.g. IFNa-induced genes and
of cytokine and chemokine genes (see Protocol S1 for the detailed
list of genes) was analyzed for significant fold change over baseline
at day 10 and day 45+ in two groups, including all 4 AGMs or 4
PTs. From this selected list of genes, only those showing greater
than 99% probability of being differentially expressed (p#0.01)
and an expression level change of 2-fold or greater in at least one
of the error-weighted combines on either day 10 or day 45+ for
colon or blood (IFNa-induced genes) or for colon alone (cytokine
and chemokine genes), were included for transcriptional profiling,
as presented in Figure 2B and 2C and Table S1. Primary data will
be available in the public domain through Expression Array
Manager at http://expression.viromics.washington.edu/, in ac-
cordance with proposed MIAME standards, while a more
complete analysis of the microarray dataset, including lymph
nodes, is presented in the companion paper (Lederer et al.).
For gene expression by real-time RT-PCR, 1 mg of total DNA-
free RNA from PBMCs, lymph node, and colon per animal per
time point was retrotranscribed (Omniscript Reverse Transcrip-
tion kit, Qiagen) with random primers (Stratagene, La Jolla, CA)
supplemented with RNasin Plus RNase inhibitor (Promega,
Madison, WI). Real-time PCR was run in duplicate for the
HPRT housekeeping gene and the target gene on the same 96-well
optical plate (Applied Biosystems, Foster City, CA) in a 25 ml
Figure 5. Differential dynamics of Tregs after acute SIV infection of PTs and AGMs. Frequency (A) and absolute number (B) of FoxP3+CD4+
T cells amongst total CD4+ T cells in PBMCs. (C) FACS detection of FoxP3 and Ki67 in peripheral blood CD4+ T cells as a function of time after infection
in a representative PT (A99059) and AGM (06006). (D) Frequency of FoxP3+ cells in the lymph nodes both within CD4+ T cells. Quantitative analysis (E)
and immunohistochemistry (F) of FoxP3-expressing cells within the paracortical T cell zone of lymph nodes (left) and in the lamina propria of colon
biopsies (right). Refer to Figure 1 for a description of statistical analysis and symbols.
doi:10.1371/journal.ppat.1000295.g005
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reaction volume containing 5 ml cDNA (1/10 of RT product) plus
25 ml Mastermix (Applied Biosystems) and run on a real-time
quantitative thermocycler (ABI PRISM 7700) following manufac-
turer’s instructions. Primer-probe sets from Applied Biosystems
included IL-17A rhesus (Rh02621750_m1), RORC
(Hs01076112_m1), FoxP3 (Hs00203958_m1) and HPRT
(Hs99999909_m1). Results were analyzed with the SDS 7900
system software, version 2.1 (Applied Biosystems). Cytokine
mRNA expression levels were calculated from normalized DCT
values as compared to HPRT. All samples from days 214, 10, and
45+ were run on the same plate for each target genes.
Cell counts, phenotype, and functional analysis by flow
cytometry
Panels of antibodies used for multiparameter flow cytometry are
listed in Table S2 (including clone, manufacturer, and dilution).
FACS analysis was performed on one or two four-laser BD LSR-II
flow cytometers using High Throughput System (HTS) plate
readers (BD Biosciences) and data were analyzed using FlowJo
software v6-8 (Treestar, Ashland, OR).
Complete blood counts (CBC) were determined at the
WaNPRC Clinical Lab in Seattle as well as by absolute counting
on 50 ml whole blood, using Trucount absolute counting tubes
(BD Biosciences, San Jose, CA). Cells counts in bone marrow were
determined on Trucount tubes only, using 10 ml of bone marrow
suspension. Phenotyping was performed by cell surface staining
and, when necessary, by intracellular staining (Fix/Perm and
Perm/wash buffers, BD or FoxP3 buffer set; Biolegend, San
Diego, CA), following manufacturer’s instructions (Table S2).
Multifunctional cytokine assays were performed in vitro after no
stimulation or after stimulation of 5–86105 cells with 5 mg/ml of
SIVagm.sab92018 peptide pools (see Protocol S1 for details) or
polyclonal activators (e.g., concanavilin A, 10 mg/ml; and PMA,
10 ng/ml; and ionomycin, 1 mg/ml) for 8–12 hours.
FACS data were analyzed using FlowJo software with standard
gating strategies and then transferred into analysis and graphic
software including Excel (Windows), StatView (Abacus Concepts,
Berkeley, CA), SPICE (kindly provided by Dr. M. Roederer of the
Vaccine Research Center, NIAID/NIH, Bethesda, MD), and
Graphpad Prism4 (San Diego, CA). Multifunctional cytokine
analysis was performed after stringent gating of each cytokine
positive population and subsequent Boolean gating (FlowJo). All
graphic data were represented on an absolute scale representing
the frequency of the combination of cytokines secreted over time
in CD4+ or CD8+ T cell populations (see Protocol S1 for more
details).
Histology, immunohistochemistry, and quantitative
image analysis
H&E stained sections of lymph nodes and colon from paraffin-
embedded biopsies and necropsy samples were examined by semi-
quantitative histopathology analysis. For immunohistochemistry,
all slides were stained using the Dako Autostainer (Dako Inc.,
Carpenteria, CA) and primary antibodies including biotin-labeled
goat anti-MIG serum (R&D systems Minneapolis, MN), polyclon-
al anti-FoxP3 rabbit serum (Abcam, Cambridge, MA), polyclonal
anti-CD8 rabbit serum (DBS, Pleasanton, CA), and polyclonal
anti-Ki67 rabbit serum (Lab Vision, Fremont, CA). Tris-buffered
saline (TBS) with Tween-20 (Dako Inc., Carpenteria CA) was used
for all washes and as a diluent for antibody (Dako Inc.,
Carpenteria CA). Prior to staining, slides were subjected to an
antigen retrieval step consisting of incubation in AR10 (Biogenex
Inc, San Ramon, CA) for 2 min at 123uC in the Digital
Decloaking Chamber (Biocare Medical Inc., Concord, CA),
followed by cooling to 90uC before rinsing in running water and
a final buffer rinse. Non-specific binding sites were blocked with a
30-minute incubation in DAKO protein block (Dako, Inc.,
Carpinteria CA) between the first primary antibody incubation
and detection reagents, and the addition of second primary
antibody and detection reagents. Primary antibodies were
replaced by normal rabbit IgG (Zymed Inc., South San Francisco,
CA) and included with each staining series as the negative control.
Avidin-biotin complex (ABC complex) method and EnVision
system (Dako, Inc., Carpinteria CA) were used as detection
systems. DAB and Vector SG (Vector, Burlingame, CA) were used
as chromogens.
Slides were visualized with a Zeiss Axioplan 2 microscope (Carl
Zeiss Inc, Thornwood, NY). Digital images were captured and
analyzed using a Zeiss Axiocam System and Openlab software
(Inprovision Inc., Waltham, MA). One section per tissue with
representative histomorphologic components (cortex, paracortex,
follicles, medulla for LN; and epithelium, lamina propria, and
muscularis mucosa for colon) was analyzed. Five high-power (406)
microscope fields of the T cell rich zone (paracortex) per LN
section and five high-power fields of lamina propria from colon
sections were randomly chosen and captured digitally with the
system described above. Each captured field includes an area of
approximately 0.09 mm2. Individual positive cells in the five
captured high-power microscope fields of the immunohistochem-
ical tissue sections were counted manually by a single observer.
The numbers of positive cells are presented as cells per square
millimeter.
Measurement of plasma factors by ELISA
Plasma was stored at 280 C prior to analysis. Cytokine and
lipopolysaccharide-binding protein (LBP) were measured using
ELISA kits for IL-6 (Cytokine Bead Array for on–human primates;
BD Biosciences, San Jose, CA), IL-12 (monkey) (U-Cytech CM,
Utrecht, The Netherlands), IFNa (human) (PBL Biomedical
Laboratories, Piscataway, NJ), and LBP (HK315) (Hycult
Biotechnology, Uden, The Netherlands).
Statistical analysis
Intracellular cytokine responses were analyzed using primarily
Wilcoxon-Rank test, supplemented with Student t-test, as part of
the SPICE platform comparing results at any time point to a day 0
reference. The Mann-Whitney U test was used for 2-group
Figure 6. Loss of balance between Th17 and Treg cells correlates with pathogenic SIV infection and sustained immune activation
after acute SIV infection of PTs and AGMs. Time- and species-dependent changes in the ratio of Th17/Treg for IL-17-producing CD4+ T cells and
FoxP3+CD4+ T cells in the peripheral blood, as measured by flow cytometry (A) and by the fold change of the normalized mRNA expression levels of
IL-17A (lymph node) or RORc (colon) over those of FoxP3 (B). (C) Ratio of Th1(IFNc)/Treg as a function of time after infection. (D) Relationship between
the Th17/Treg ratio in the peripheral blood, in lymph nodes and in colon to the degree of systemic immune activation, as measured by the fraction of
Ki67+CD8+ T cells in blood (left and right) and in the lymph nodes (upper-middle) and by the density of Ki67+CD8+ cells in the paracortical T cell zone
of lymph nodes (lower-middle) at viral and immunological set points (days 28 and 45+). Refer to Figure 1 and Figure 4 for a description of statistical
analysis and symbols. Spearman’s rank test was used to determine correlations between variables.
doi:10.1371/journal.ppat.1000295.g006
Loss of Th17 and Treg Balance in SIV Infection
PLoS Pathogens | www.plospathogens.org 14 February 2009 | Volume 5 | Issue 2 | e1000295
comparison between AGMs and PTs for each time point, whereas
ANOVA was used to test differences over time compared to
baseline for each group. For ratios and values expressed on log-
transformed values (Th17/Treg, Th1/Treg, RORc/FoxP3), both
ANOVA and Mann-Whitney U test were run to test differences
over time. Mixed-effects longitudinal statistical models were used
to test the impact of CD4+ T cell subsets (Th17, Treg, Th1), ratio
(Th17/Treg), blood CD4 counts or CD4 loss, as well as viral load,
on CD8+ T cell activation levels (%Ki67) during the infection
period (day3 and thereafter). These models were run in the SAS
System 9.2 and specified random effects for time and the
individual. Spearman’s rank correlation was used to determine
correlations between variables. P values,0.05 were considered
statistically significant.
Supporting Information
Figure S1 Plasma viral load, T cell activation, and CD4+ and
CD8+ T cell changes after SIV infection of PTs and AGMs. (A)
Plasma viral load measured before and after inoculation of 4 PTs
and 4 AGMs with the SIVagm isolate, SIVagm.sab92018 (600
TCID50). (B) Flow histograms showing the distribution of Ki67
expression in peripheral blood CD4+ T cells in a representative PT
(J96082) and AGM (04005) before and after infection. (C–D)
Immunohistochemistry (left) and quantitative image analysis (right)
of (C) Ki67+CD8+ T cells (blue- and brown-colored) and (D)
CXCL9/MIG-expressing (brown-colored) in the paracortical T
cell zone (lymph node) and in the lamina propria (colon). (E) Flow
cytograms showing the distribution of CD4+ and CD8+ T cells
before and after infection of a representative PT (J96082) and
AGM (06005), in peripheral blood (upper), lymph node (lower
left), and colon (lower right). (F) Flow cytograms showing the
distribution of naı¨ve (CD45RA+CD27+), memory
(CD45RA2CD27+), effector (CD45RA2CD272), and terminally
differentiated effector (CD45RA+CD272) subpopulations among
CD8+, CD4+ and CD3+DN T cells in one representative PT
(J96082) and one representative AGM (06005). (G) Changes in T
cell subpopulations after acute infection (see the legend to the left),
depicted as pie-chart representations of the average mean
frequencies of each of these subpopulations in PTs and AGMs,
as a function of time post-infection in the peripheral blood (middle)
and lymph nodes (right) in CD4+ PBMCs (upper) or CD8+
PBMCs (lower). Data are presented as means+/2SEM. Statistical
analysis: P values were obtained on a per group basis (*) using the
Mann-Whitney nonparametric test (when comparing PTs to
AGMs at a given time point) or over time (#) by ANOVA (linear
scale) or Mann-Whitney (for log transformed values and ratios)
(comparing each time point separately to baseline, e.g. day 214
and day 0, in PTs or AGMs). Statistical analysis of subset cell
composition (pie chart) was obtained by permutation analysis
comparing each time point to baseline (day 214 and day 0) using
SPICE software. When the p value is not indicated on the graph,
‘‘*’’ or ‘‘#,’’ indicate that p,0.05 for each test, respectively. NS
means ‘‘not statistically significant.’’
Found at: doi:10.1371/journal.ppat.1000295.s001 (6.86 MB PDF)
Figure S2 Changes in the frequency of multifunctional CD4+
and CD8+ T cells as a function of time post-infection in PTs and
AGMs. (A) The frequency of multifunctional CD4+ T cells
producing IL-2, TNFa, IFNc, IL-17, and/or MIP1b was assessed
by 10-color flow cytometry, analyzing cells secreting all 32 possible
combinations of 1, 2, 3, 4 and/or 5 cytokines, with Boolean gating
(FlowJo platform) and SPICE software (M. Roederer; described in
Protocol S1). Rectangles R1, R2, and R3 highlight changes in the
frequency of certain subpopulations that occurred over time
primarily in the PT but not the AGM, whereas rectangle R4
highlights changes that occurred primarily in the AGM.
Rectangles A, B, and C highlight IL-17+ subpopulations that also
express IL-2 and TNFa (A), IL-2 alone (B), or no other cytokine
from this list (C). Individual animals are represented by dots,
means by dashed lines, and interquartile ranges by bars. P values
(,0.05) were obtained using the Student’s t-test (+) or Wilcoxon-
Rank test (#), comparing mean values to the baseline values (day
0) for each species, as provided by SPICE software. (B) FACS
detection of IL-17 (x-axis) and IL-2, TNFa, IFNc, or MIP1b (y-
axis) within CD3+CD4+ T cells over time in a representative PT
(A99073) and AGM (06004) after PMA and ionomycin stimulation
in vitro. (C) Differential representation of IL-17 (x-axis) and IL-2,
TNFa, IFNc, or MIP1b (y-axis) within CD3+CD4+ T cells in the
peripheral blood, spleen and mesenteric lymph nodes of one
representative PT (A99028) and one AGM (06005) at necropsy
(day 45+).
Found at: doi:10.1371/journal.ppat.1000295.s002 (1.31 MB PDF)
Figure S3 FoxP3+ T cell populations in the PT and AGM, pre-
and post-infection. (A) FoxP3 and CD127 (IL-7 receptor)
expression on CD4+ T cells in PBMCs [from a chronically
SIVagm.sab92018-infected AGM (18 months post-infection)]. (B)
CD25-enriched (‘‘CD25+ Pos. Selection’’) fractions using anti-
CD25 magnetic beads, stimulated in vitro, and then analyzed for
expression of IL-17, IL-2 or IFNc, and FoxP3. (C–D) Suppression
of cell division by total CD25+ Tregs from PBMCs [from
chronically SIVagm.sab92018-infected AGMs (18 months post-
infection)] on CFSE labeled CD252 PBMCs (Responder) gated on
CD4+ T cells or CD8+ T cells with or without Treg add-back at a
ratio of 1:4 with responder cells (C-left). The same donor was
tested with a dynamic range of Treg over responding cells with the
frequency of undivided fraction indicated in CD4+ T cells or
CD8+ T cells (C-right), showing augmented frequency of
undivided cells as Treg/responder ratio increased. The same
results were obtained when proliferation was analyzed using the
FlowJo proliferation platform (D) from another AGM [% of
Divided cells, Division index and Proliferation index], with data
points indicating the % divided, proliferation index or division
index achieved by CFSE-labeled cells in each sample as a
percentage of the maximal value obtained in the CD25-depleted
population with no add-back. (E. F) Simultaneous FoxP3 and Ki67
expression in CD4+ and DN T cells in the peripheral blood (upper)
and axillary lymph node (lower) of a representative PT (A99059)
(E) and AGM (06004) (at day 45+) (F). Also shown in each panel is
the gating strategy for singlets, lymphocytes and CD3+ T cells. (G)
FoxP3 mRNA levels in lymph node (upper) and colon (lower), as
measured by real-time RT-PCR for FoxP3, with P values
indicated in the PT lymph node and colon compared to baseline.
Found at: doi:10.1371/journal.ppat.1000295.s003 (5.66 MB PDF)
Protocol S1
Found at: doi:10.1371/journal.ppat.1000295.s004 (0.10 MB
DOC)
Table S1 IFNa-induced and cytokine/chemokine transcripts
analyzed in the arrays of Figure 2, B and C (see Protocol S1 for
more details).
Found at: doi:10.1371/journal.ppat.1000295.s005 (0.21 MB PDF)
Table S2 Antibody panels for multiparameter flow cytometry.
BD: BD Bioscience, San Jose, CA; Coulter: Beckman Coulter, Inc.
Fullerton, CA, eBiosciences: eBiosciences, San Diego, CA;
Biolegend: Biolegend, San Diego, CA, R&D: R&D Systems, Inc,
Minneapolis, MN; Cedarlane: Cedarlane Laboratories Ltd.
Burlington, NC; NPRR: National Institutes of Health (NIH)
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Nonhuman Primate Reagent Resource (NPRR) from K. Reimann
(Harvard University, Cambridge, MA). CD38-FITC (OKT-10) is
kind gift from R. Reyes, UCSF, San Francisco, CA.
Found at: doi:10.1371/journal.ppat.1000295.s006 (0.34 MB PDF)
Text S1 This text provides information related to the low
frequency and absolute number of CD4+ T cells in the AGMs, as
presented in Figures 1E and S1E.
Found at: doi:10.1371/journal.ppat.1000295.s007 (0.05 MB
DOC)
Text S2 This text adds information related to T cell subpopu-
lations as presented in Figures S1F and S1G.
Found at: doi:10.1371/journal.ppat.1000295.s008 (0.04 MB
DOC)
Text S3 This text provides information related to the charac-
terization of CD3+ CD42CD82 double negative cells (DN) as
presented in Figures S1E and S1F.
Found at: doi:10.1371/journal.ppat.1000295.s009 (0.05 MB
DOC)
Text S4 This text provides information related to Figure 4, A
and B and Figure S2 related to the dynamic of Th1 and Th2/Treg
CD4+ T cell populations as well as to SIV antigen-specific CD4+
and CD8+ T cell responses.
Found at: doi:10.1371/journal.ppat.1000295.s010 (0.06 MB
DOC)
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